US Stock MarketDetailed Quotes

EVAX Evaxion Biotech

Watchlist

1.570
-0.040-2.48%

Close Nov 27 16:00 ET

9.21MMarket Cap-560P/E (TTM)

Evaxion Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

31.36%-17.69M

-17.51%-25.77M

30.69%-5.19M

-102.87%-8.19M

-76.34%-21.93M

-4.12M

-127.67%-6.3M

-225.14%-7.49M

-36.78%-4.04M

-77.20%-12.44M

Net income from continuing operations

4.51%-22.13M

5.56%-23.17M

30.08%-4.77M

-41.49%-5.79M

-63.35%-24.53M

---8.37M

-30.92%-5.25M

-87.34%-6.82M

-32.07%-4.09M

-34.15%-15.02M

Operating gains losses

28.61%-282K

---395K

----

Depreciation and amortization

7.71%615K

65.99%571K

----

227.62%344K

----

29.63%105K

Deferred tax

1.40%-984K

-425.26%-998K

----

90.81%-190K

----

-150.55%-2.07M

Other non cash items

356.23%1.36M

46.57%-530K

-1,271.43%-820K

86.81%-129K

-824.09%-992K

--54K

-112.79%-138K

-69.30%70K

-292.90%-978K

-4.86%137K

Change In working capital

154.29%1.56M

-332.58%-2.88M

157.86%427K

-308.96%-2.17M

475.35%1.24M

--1.84M

-645.78%-906K

-348.48%-738K

389.94%1.04M

-62.48%215K

-Change in receivables

174.50%1.11M

-179.76%-1.49M

----

174.49%1.86M

----

-642.14%-2.5M

-Change in payables and accrued expense

132.71%455K

-122.20%-1.39M

----

-123.05%-626K

----

198.46%2.72M

Cash from discontinued investing activities

Operating cash flow

31.36%-17.69M

-17.51%-25.77M

30.69%-5.19M

-102.87%-8.19M

-76.34%-21.93M

---4.12M

-127.67%-6.3M

-225.14%-7.49M

-36.78%-4.04M

-77.20%-12.44M

Investing cash flow

Cash flow from continuing investing activities

65.30%-93K

79.85%-268K

84.44%-77K

51.38%-159K

-238.42%-1.33M

-177K

-6,520.00%-331K

-1,000.00%-495K

-303.70%-327K

-477.94%-393K

Net PPE purchase and sale

70.21%-87K

77.54%-292K

83.73%-83K

35.82%-181K

-263.13%-1.3M

---176K

-16,500.00%-332K

-5,000.00%-510K

-340.63%-282K

-426.47%-358K

Net intangibles purchase and sale

--0

----

--0

-71.43%-60K

--0

---60K

---35K

Net investment purchase and sale

-125.00%-6K

-20.00%24K

-60.00%6K

46.67%22K

--30K

---1K

133.33%1K

--15K

188.24%15K

----

Cash from discontinued investing activities

Investing cash flow

65.30%-93K

79.85%-268K

84.44%-77K

51.38%-159K

-238.42%-1.33M

---177K

-6,520.00%-331K

-1,000.00%-495K

-303.70%-327K

-477.94%-393K

Financing cash flow

Cash flow from continuing financing activities

36.14%10.69M

-84.23%7.85M

-757.14%-300K

-69.36%7.74M

464.87%49.81M

24.65M

-101.00%-65K

-94.44%-35K

140,388.89%25.25M

-7.27%8.82M

Net issuance payments of debt

-108.51%-632K

2,669.20%7.43M

-205.71%-107K

18,095.35%7.74M

-290.54%-289K

---144K

-252.63%-67K

-94.44%-35K

-138.89%-43K

-193.67%-74K

Net common stock issuance

2,042.06%9.17M

-99.21%428K

--28K

--0

497.12%53.85M

--25.95M

-99.98%1K

--0

--27.9M

-4.48%9.02M

Proceeds from stock option exercised by employees

--2.59M

--0

----

--0

----

Net other financing activities

---432K

----

-2,837.50%-3.76M

---1.16M

--1K

--0

---2.61M

-884.62%-128K

Cash from discontinued financing activities

Financing cash flow

36.14%10.69M

-84.23%7.85M

-757.14%-300K

-69.36%7.74M

464.87%49.81M

--24.65M

-101.00%-65K

-94.44%-35K

140,388.89%25.25M

-7.27%8.82M

Net cash flow

Beginning cash position

-59.01%13.18M

451.35%32.17M

16.52%31.41M

451.35%32.17M

-38.97%5.83M

--11.94M

360.20%18.8M

324.82%26.96M

-38.97%5.83M

28.60%9.56M

Current changes in cash

61.00%-7.09M

-168.53%-18.19M

30.57%-5.57M

-102.91%-607K

761.40%26.54M

--20.36M

-280.40%-6.69M

-238.88%-8.02M

785.14%20.89M

-265.76%-4.01M

Effect of exchange rate changes

35.94%-508K

-277.62%-793K

-327.54%-590K

-164.94%-150K

-172.92%-210K

---139K

-302.47%-164K

-230.19%-138K

240.00%231K

197.63%288K

End cash Position

-57.65%5.58M

-59.01%13.18M

34.33%25.25M

16.52%31.41M

451.35%32.17M

--32.17M

51.67%11.94M

360.20%18.8M

324.82%26.96M

-38.97%5.83M

Free cash flow

31.80%-17.78M

-11.90%-26.07M

34.07%-5.27M

-91.16%-8.37M

-81.54%-23.29M

---4.29M

-139.50%-6.63M

-240.63%-8M

-45.22%-4.38M

-81.05%-12.83M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	31.36%-17.69M	-17.51%-25.77M	30.69%-5.19M	-102.87%-8.19M	-76.34%-21.93M	-4.12M	-127.67%-6.3M	-225.14%-7.49M	-36.78%-4.04M	-77.20%-12.44M
Net income from continuing operations	4.51%-22.13M	5.56%-23.17M	30.08%-4.77M	-41.49%-5.79M	-63.35%-24.53M	---8.37M	-30.92%-5.25M	-87.34%-6.82M	-32.07%-4.09M	-34.15%-15.02M
Operating gains losses	28.61%-282K	---395K	----	----	----	----	----	----	----	----
Depreciation and amortization	7.71%615K	65.99%571K	----	----	227.62%344K	----	----	----	----	29.63%105K
Deferred tax	1.40%-984K	-425.26%-998K	----	----	90.81%-190K	----	----	----	----	-150.55%-2.07M
Other non cash items	356.23%1.36M	46.57%-530K	-1,271.43%-820K	86.81%-129K	-824.09%-992K	--54K	-112.79%-138K	-69.30%70K	-292.90%-978K	-4.86%137K
Change In working capital	154.29%1.56M	-332.58%-2.88M	157.86%427K	-308.96%-2.17M	475.35%1.24M	--1.84M	-645.78%-906K	-348.48%-738K	389.94%1.04M	-62.48%215K
-Change in receivables	174.50%1.11M	-179.76%-1.49M	----	----	174.49%1.86M	----	----	----	----	-642.14%-2.5M
-Change in payables and accrued expense	132.71%455K	-122.20%-1.39M	----	----	-123.05%-626K	----	----	----	----	198.46%2.72M
Cash from discontinued investing activities
Operating cash flow	31.36%-17.69M	-17.51%-25.77M	30.69%-5.19M	-102.87%-8.19M	-76.34%-21.93M	---4.12M	-127.67%-6.3M	-225.14%-7.49M	-36.78%-4.04M	-77.20%-12.44M
Investing cash flow
Cash flow from continuing investing activities	65.30%-93K	79.85%-268K	84.44%-77K	51.38%-159K	-238.42%-1.33M	-177K	-6,520.00%-331K	-1,000.00%-495K	-303.70%-327K	-477.94%-393K
Net PPE purchase and sale	70.21%-87K	77.54%-292K	83.73%-83K	35.82%-181K	-263.13%-1.3M	---176K	-16,500.00%-332K	-5,000.00%-510K	-340.63%-282K	-426.47%-358K
Net intangibles purchase and sale	--0	--0	----	--0	-71.43%-60K	--0	--0	--0	---60K	---35K
Net investment purchase and sale	-125.00%-6K	-20.00%24K	-60.00%6K	46.67%22K	--30K	---1K	133.33%1K	--15K	188.24%15K	----
Cash from discontinued investing activities
Investing cash flow	65.30%-93K	79.85%-268K	84.44%-77K	51.38%-159K	-238.42%-1.33M	---177K	-6,520.00%-331K	-1,000.00%-495K	-303.70%-327K	-477.94%-393K
Financing cash flow
Cash flow from continuing financing activities	36.14%10.69M	-84.23%7.85M	-757.14%-300K	-69.36%7.74M	464.87%49.81M	24.65M	-101.00%-65K	-94.44%-35K	140,388.89%25.25M	-7.27%8.82M
Net issuance payments of debt	-108.51%-632K	2,669.20%7.43M	-205.71%-107K	18,095.35%7.74M	-290.54%-289K	---144K	-252.63%-67K	-94.44%-35K	-138.89%-43K	-193.67%-74K
Net common stock issuance	2,042.06%9.17M	-99.21%428K	--28K	--0	497.12%53.85M	--25.95M	-99.98%1K	--0	--27.9M	-4.48%9.02M
Proceeds from stock option exercised by employees	--2.59M	--0	----	----	--0	----	----	----	----	----
Net other financing activities	---432K	----	----	----	-2,837.50%-3.76M	---1.16M	--1K	--0	---2.61M	-884.62%-128K
Cash from discontinued financing activities
Financing cash flow	36.14%10.69M	-84.23%7.85M	-757.14%-300K	-69.36%7.74M	464.87%49.81M	--24.65M	-101.00%-65K	-94.44%-35K	140,388.89%25.25M	-7.27%8.82M
Net cash flow
Beginning cash position	-59.01%13.18M	451.35%32.17M	16.52%31.41M	451.35%32.17M	-38.97%5.83M	--11.94M	360.20%18.8M	324.82%26.96M	-38.97%5.83M	28.60%9.56M
Current changes in cash	61.00%-7.09M	-168.53%-18.19M	30.57%-5.57M	-102.91%-607K	761.40%26.54M	--20.36M	-280.40%-6.69M	-238.88%-8.02M	785.14%20.89M	-265.76%-4.01M
Effect of exchange rate changes	35.94%-508K	-277.62%-793K	-327.54%-590K	-164.94%-150K	-172.92%-210K	---139K	-302.47%-164K	-230.19%-138K	240.00%231K	197.63%288K
End cash Position	-57.65%5.58M	-59.01%13.18M	34.33%25.25M	16.52%31.41M	451.35%32.17M	--32.17M	51.67%11.94M	360.20%18.8M	324.82%26.96M	-38.97%5.83M
Free cash flow	31.80%-17.78M	-11.90%-26.07M	34.07%-5.27M	-91.16%-8.37M	-81.54%-23.29M	---4.29M	-139.50%-6.63M	-240.63%-8M	-45.22%-4.38M	-81.05%-12.83M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data